AstraZeneca’s immunotherapy drug wins key lung cancer approval

AstraZeneca’s immunotherapy drug wins key lung cancer approval AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors. The U.S. Food and Drug Administration said late on Friday it […]